Pelvic fl oor disorders that affect stool evacuation include structural (for example, rectocele) and functional disorders (for example, dyssynergic defecation (DD)). Meticulous history, digital rectal examination (DRE), and physiological tests such as anorectal manometry, colonic transit study, balloon expulsion, and imaging studies such as anal ultrasound, defecography, and static and dynamic magnetic resonance imaging (MRI) can facilitate an objective diagnosis and optimal treatment. Management consists of education and counseling regarding bowel function, diet, laxatives, most importantly behavioral and biofeedback therapies, and fi nally surgery. Randomized clinical trials have established that biofeedback therapy is effective in treating DD. Because DD may coexist with conditions such as solitary rectal ulcer syndrome (SRUS) and rectocele, before considering surgery, biofeedback therapy should be tried and an accurate assessment of the entire pelvis and its function should be performed. Several surgical approaches have been advocated for the treatment of pelvic fl oor disorders including open, laparoscopic, and transabdominal approach, stapled transanal rectal resection, and robotic colon and rectal resections. However, there is lack of well-controlled randomized studies and the effi cacy of these surgical procedures remains to be established.
INTRODUCTION
Pelvic fl oor disorders are common and cause signifi cant bowel problems. Th e pelvic fl oor is a complex muscular apparatus within the pelvis and serves defecation, micturition, and sexual functions. Th e most common pelvic fl oor disorders are fecal and urinary incontinence and pelvic organ prolapse. Approximately 23.7 % of women have at least one pelvic fl oor disorder and 2.9 % have pelvic organ prolapse ( 1 ) .
Here, we focus on recent advances in the management of pelvic fl oor disorders aff ecting defecation, with a brief overview of pathophysiology and diagnosis. Th ese disorders aff ect both women and men and necessitate a multidisciplinary team approach involving colorectal surgeon, gastroenterologist, pain specialist, physical therapist, radiologist, urogynecologist, and urologist.
PELVIC FLOOR ANATOMY AND NORMAL PHYSIOLOGY
Th e pelvic fl oor has superfi cial and deep muscle layers that interlace and envelope the rectum, bladder, and uterus. Th e superfi cial layers include the internal anal sphincter (IAS) and external anal sphincter (EAS), perineal body, and transverse perinei muscles ( 2 ) . Th e deeper pelvic muscles, also known as levator ani, consist of the pubococcygeus, ileococcygeus, and puborectalis. Th e puborectalis maintains anorectal angulation and creates a mechanical barrier for stool fl ow and maintains pelvic fl oor integrity, and its disruption / dysfunction may cause common pelvic fl oor disorders ( 3, 4 ) . Th e pelvic fl oor receives nerve supply from the pudendal and perineal nerves and sympathetic and parasympathetic nerves. Branches from the sacral nerve roots of S2, S3, and S4 innervate the pelvic fl oor muscles. Th e puborectalis muscle (middle layer of pelvic fl oor muscle) is actually innervated by the pudendal nerve and the deep muscles (pubococcygeus, ileococcygeus, and coccygeus) are innervated by the direct branches of sacral nerve roots S3 and S4 ( 3 ) . Pudendal nerve damage may cause dysfunction of puborectalis muscle and EAS muscles (both constrictor muscles) and this in turn may cause fecal incontinence. During normal defecation, the voluntary eff ort of bearing down increases the intraabdominal pressure, together with the contraction of the rectum and perineal muscles. Simultaneously, the anal sphincters and puborectalis relax, the anorectal angle widens, and the perineum descends. Th ese sequential movements facilitate the movement of stool from the rectum, resulting in stool evacuation ( Figure 1 ).
DYSSYNERGIC DEFECATION
Dyssynergic defecation (DD) is characterized by paradoxical anal contraction, inadequate anal relaxation, and / or impaired push eff ort caused by incoordination of abdominal, rectal, and anal
Medical and Surgical Management of Pelvic Floor Disorders Affecting Defecation
muscles ( 5 ) . Th e most common symptoms are excessive straining (84 % ), feeling of incomplete evacuation (76 % ), abdominal bloating (74 % ), passage of hard stools (65 % ) and < 3 bowel movements per week (62 % ). Digital maneuvers are frequent ( ~ 35 % ), although infrequently reported ( 6 ) .
Diagnosis
Th e diagnosis of DD requires fulfi llment of symptomatic (Rome III) and manometric criteria, with one other quantifi able measure of abnormal defecation such as abnormal balloon expulsion test, prolonged delay in colonic transit, or incomplete evacuation during defecography ( 7 ).
Digital rectal exam (DRE)
Digital rectal exam (DRE) is a useful bedside screening tool. Th e exterior inspection can detect skin excoriation, squamous cell cancer, skin tags, anal fi ssures, fi stulas, or hemorrhoids. Th e perineal sensation (to exclude neuropathy) is evaluated by gently stroking the perianal skin with a cotton bud in all four quadrants.
Digital penetration may reveal a stricture, spasm, tenderness, mass, blood, or stool. If there is a lack of awareness of stool in the rectum this may suggest rectal hyposensitivity.
Primarily, the resting tone is evaluated, and by asking the subject to squeeze it is possible to evaluate the anal sphincter and puborectalis muscle. Th e patient is asked to push and bear down as if to defecate, and during this maneuver, the examiner should perceive relaxation of the EAS and / or the puborectalis muscle, together with perineal descent. An absence of these normal fi ndings should raise the index of suspicion for an evacuation disorder such as DD. DRE has a sensitivity of 77 % and specifi city of 87 % for detecting dyssynergia ( 8 ) , but is infrequently performed, even by gastroenterologists, and there is lack of training ( 9 ) . Th us, a concerted eff ort is needed to improve the training of digital rectal examination.
Anorectal manometry
Th is test provides information regarding rectal and anal pressures at rest and during simulated defecation. During rectal balloon distention it provides information regarding rectal compliance and sensation, and rectoanal refl exes ( 10 ) . Normal subjects can exhibit dyssynergia when attempting to defecate in the left lateral position; hence, manometric changes are best assessed with the patient on a commode and with a sensation of stooling ( 11, 12 ) . Th e best method to diagnose dyssynergia is to distend a balloon in the rectum and ask the subject to attempt evacuation in a sitting position ( 13, 14 ) . Four patterns of dyssynergia have been described, and their identifi cation helps tailor biofeedback therapy. Type I is adequate push eff ort with paradoxical anal contraction, type II is impaired push eff ort with paradoxical anal contraction, type III is impaired anal relaxation with adequate push eff ort, and type IV is impaired push eff ort with impaired anal relaxation. Th ese patterns were established with the conventional manometry, which is very useful and still widely used in many centers. Th e new HRM system (Sierra Scientifi c Instruments, Los Angeles, CA) allows interpolation of manometric recordings from 12 circumferential pressure sensors into a detailed topographical plot. Th is system can provide a greater resolution of the intraluminal pressure changes with more anatomical detail, hopefully leading to a better assessment of common pelvic fl oor disorders ( 15 ) ( Figure 2a,b ) .
Balloon expulsion test
Th is provides information regarding the ability to expel a 50-ml water-fi lled balloon placed in the rectum. Normal expulsion time is 1 min. It has 80 -90 % specifi city and 97 % negative predictive value for identifying dyssynergia. Although it has a sensitivity of only 50 % , it is a simple and useful screening procedure to identify constipated patients who do not have dyssynergia ( 16 In adsorbed on activated charcoal) coated with the pH-sensitive polymer methacrylate that dissolves in the alkaline terminal ileum, releasing the radioisotope into the lumen. Th e clinical utility of scintigraphic testing has been demonstrated in previous studies. Th e colonic transit scintigraphy is recommended for assessing colonic transit in patients with constipation or diarrhea, but it is available in a limited number of centers ( 18 ) .
Wireless motility capsule test (SmartPill)
Th e Wireless Motility Capsule (Smart Pill Corporation, Buff alo, NY) is a wireless pH, temperature, and pressure recording capsule. Th is novel, valuable ambulatory technique of assessing regional (gastric, small bowel, colonic) and whole-gut transit time without radiation off ers a standardized method of identifying normal and slow colonic transit ( 18 -20 ) and recommended as useful by the American Neurogastroenterology & Motility Society. Currently, the Food and Drug Administration (FDA) has approved the SmartPill GI Monitoring System, version 2.0, for the evaluation of colonic transit time in patients with suspected chronic constipation (CC), and for evaluating patients with suspected gastroparesis.
Three-dimensional anal ultrasonography
Th e three-dimensional endoanal ultrasonography provides excellent anatomical details of the anal sphincter complex, including coronal and segmental sections. It is well tolerated and inexpensive. Th e sphincter anatomy can be evaluated spatially, and " damaged " sphincter integrity and volume as well as fi stulous track(s) or potential fl uid collections can be assessed ( 21 ) .
MR (magnetic resonance) defecography
MR defecography visualizes the pelvic viscera and supporting softtissue structures without radiation, but it is not widely available.
It can be performed with a closed or open system. Open magnetic resonance imaging (MRI) acquires images in a sitting position, simulating true defecation. In a closed-confi guration MRI system, images are acquired in the supine position ( 22 ) . A recent study demonstrated that dynamic MR defecography with an open confi guration and low-fi eld tilting MR system is feasible ( 23 ) .
MANAGEMENT OF GENERAL AND SUPPORTIVE THERAPIES
Medical treatment consists of avoiding constipating medications, increasing fl uid and dietary fi ber intake, regular exercise, and practicing timed toilet training ( 24 ) . Th e American College of Gastroenterology (ACG) task force has defi ned levels of evidence and graded most treatments. Level I evidence was defi ned as: randomized controlled trials (RCTs) with P < 0.05, adequate sampling
Colonic transit study
Slow transit constipation can coexist in two-thirds of patients with DD, and it is imperative to differentiate between patients with isolated DD or mixed with slow transit constipation. Colon transit study is considered abnormal if more than five markers (20 % ) are present on a plain abdominal film 5 days after ingestion of a Sitzmarker capsule containing 24 radioopaque markers ( 17 ) .
Colonic transit scintigraphy
Colonic transit scintigraphy is indicated in patients with suspected colonic motility disorders or more diff use disorders ( 26 ) . However, this study was published recently and dried plums were not graded by the ACG task force. Although medications that promote bowel movement such as stool soft eners, stimulant laxatives, and osmotic laxatives can be useful in clinical practice, the ACG task force states that there is insuffi cient evidence for these treatments ( 25 ) . Th e ACG gave polyethylene glycol a grade A.
A recent 6-month study reported adequate relief of constipation in 52 % of patients treated with polyethylene glycol compared with 11 % treated with placebo ( 27 ) . Lubiprostone, a chloride channel-2 activator, at a dose of 24 μ g b.i.d. was more eff ective than placebo in improving stool frequency and symptoms of CC ( 28 ) . Prucalopride, a 5-hydroxytryptamine-4 receptor agonist, at a dose of 2 -4 mg q.d. was also eff ective in the treatment of CC, and although not FDA approved, it is approved for use in Europe ( 29 ) . Linaclotide, a luminally acting agonist of the guanylate cyclase-C receptor, produces rapid and sustained improvement of bowel symptoms, global relief, and improved quality of life ( 30 ) . It is currently under FDA review for the treatment of irritable bowel syndrome with constipation and CC.
Th us far, their effi cacy in DD has not been validated.
Biofeedback therapy
Th is is the most eff ective treatment for DD. Th e main purpose is to restore a normal pattern of defecation using " operant conditioning " techniques ( 31 ) . Th e primary goals are to: (i) correct the underlying dyssynergia; and (ii) improve rectal sensory perception. Th e goals are to improve abdominal push eff ort, facilitate pelvic fl oor relaxation, and expel artifi cial stool. Th e procedure involves placing a manometric probe into the rectum that, in turn, provides instant feedback to the patients regarding their performance and how the rectal and anal muscles are behaving. Approximately 10 -15 maneuvers are usually attempted in a single session, and the number of sessions and duration of each session are customized. Typically, 4 -6 sessions of 1 h each are performed. Several RCTs have demonstrated that biofeedback therapy is superior to sham feedback, standard therapy, or laxatives in the management of patients with DD ( 32, 33 ) . It was not benefi cial for patients with isolated slow transit constipation ( 34 ) . Recently, biofeedback has been shown to provide sustained improvement of bowel symptoms and anorectal function for up to 1 year, whereas standard therapy with laxatives was ineff ective ( 35 ) . Also, home biofeedback therapy was as eff ective as offi ce biofeedback therapy and more cost eff ective ( 36, 37 ) . Home biofeedback therapy comprised home training. Th e patients were instructed to insert a disposable two-sensor probe into the rectum. Th e probe is attached to an LCD display box and provides visual input to the subjects regarding their performance. Th e patients practiced at home twice a day for 20 min per session. When home biofeedback therapy was compared with the standard treatment of offi ce biofeedback, there was no diff erence between the two treatments, with both treatments showing signifi cant improvement in the number of complete spontaneous bowel movements per week, dyssynergia pattern, balloon expulsion time, and bowel satisfaction score. Currently, this treatment is not covered by insurance and could cost up to $ 400 per month, which may limit its application ( Table 1 ).
Rectal prolapse
Rectal prolapse is defi ned as an abnormal protrusion of all layers of the rectal wall through the anus. Th e incidence is 2.5 / 100,000, with the highest incidence among elderly women. In younger people, the gender ratio is equal ( 38 ) .
Th e primary mechanism is excessive straining that over many years gradually weakens the pelvic fl oor and its support structures. Th e repeated injury to the pudendal nerve and other nerves weakens the IAS and EAS and the puborectalis. Th e lax anal sphincters off er very little counteracting resistive force during defecation, thereby leading to an abnormal protrusion of the rectal wall through the anus. Other causes for prolapse include pudendal neuropathy from either aging or obstetric injury.
Most patients present with anal protrusion and / or passage of blood, or symptoms of obstructed defecation or fecal incontinence ( 39 ) . Pre-existing dysmotility, DD, or intussusception also predispose. Anal inspection may reveal normal anal area but when the patient bears down, the prolapsed rectum is visible, oft en edematous and sometimes with a friable and ulcerated mucosa. Rectal prolapse is graded into four types: grade 1 = up to anal verge; grade 2 = prolapse outside the anus but reduces spontaneously; grade 3 = prolapses outside the anus but can be manually reduced; and grade 4 = prolapse cannot be reduced manually.
Diagnosis
. Th e diagnosis is made through careful perineal examination and during attempted defecation. A patulous anus with full-thickness rectal protrusion is usually diagnostic. If not seen at bedside, a Valsalva maneuver on commode should bring on the prolapse; a prone jackknife position is not helpful. Endoscopic evaluation to identify other causes associated with rectal prolapse may be useful. Defecography usually demonstrates the prolapse, and may reveal an obtuse anorectal angle. MR defecography may reveal other anatomical defects that can aid in assessment of surgical intervention. Th e three-dimensional endoanal ultrasonography may show asymmetry and thickening of the IAS and submucosa. Demonstration of anal sphincter defect is useful when considering sphincter reconstruction ( 7 ) . Anorectal manometry may reveal sphincter weakness especially in patients with best candidates. Most commonly, a perineal proctosigmoidectomy (Altemeir procedure) is performed ( 44 ) . Th is may be combined with transperineal levatoroplasty that may help to reduce the risk of recurrence ( 45 ) . Recent studies have shown that robotic colorectal resection is a safe and feasible option; however, more studies are required ( 46 ) .
Recurrence rates for transabdominal rectopexy are low (0 -8 % ); however, aft er posterior rectopexy 50 % of patients complain of severe constipation ( 47 ) . Perineal procedures have a recurrence rate of 5 -21 % with similar incidence of constipation.
Rectocele
Rectocele is an abnormal sac-like protrusion of the rectal wall either toward the vagina (anterior) and rarely toward the sacrum (posterior) that often becomes apparent during defecation ( Figure 3a,b ) . It is common in adult women (20 % ), and the majority are small ( < 2 cm), asymptomatic, and require no treatment ( 1, 48 ) .
Rectocele is believed to be caused by weakness of the rectovaginal septum and / or pelvic fl oor; however, the exact etiology is not known. Obstetric injury and multiple vaginal deliveries have been proposed as precipitating factors. However, rectocele is also seen in nulliparous women ( 38, 49 ) . Th ere are no specifi c anorectal physiological fi ndings for a rectocele, and a previous study had reported that dyssynergic pattern of defecation was seen in 60 % of patients with rectocele when compared with 24 % without a rectocele ( 50 ). coexisting fecal incontinence. Rectal sensation and compliance may be either normal or impaired ( 15 ) .
Management . Grade 1 -2 prolapse that is asymptomatic does not require surgery, and could be managed with high-fi ber diet and / or laxatives, followed by biofeedback therapy to correct underlying dyssynergia. However, symptomatic grade 3 -4 prolapse requires surgery. Both abdominal and perineal approaches are available. Th e abdominal approach allows the surgeon to deal with factors that are associated with rectal prolapse including a deep culde-sac of the pouch of Douglas, lack of sacral fi xation, and redundancy of the sigmoid colon ( 40 ) . Th e method used to mobilize the rectum is controversial because of evidence suggesting that this may cause or worsen constipation in one-third of patients while decreasing the risk of prolapse recurrence. Sacral fi xation of the rectum is accomplished by either posterior suture or mesh rectopexy. Resection of sigmoid colon is preferably performed in patients with signifi cant redundancy, but is avoided in patients with the combination of diarrhea and / or incontinence as these symptoms may worsen with resection ( 41 ) .
Perineal repairs are currently the most common surgical treatment for rectal prolapse in the United States ( 42 ) . Th e perineal approach has a lower perioperative morbidity and higher recurrence rate and less satisfactory functional results ( 43 ) . In general, elderly patients, those with signifi cant medical comorbidities, or those with contraindications for abdominal surgery are oft en the 
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However, a recent study showed similar prevalence ( 51 ) . Rectocele can be a cause or a consequence of CC with excessive straining, and may be associated with DD or rectal mucosal intussusception, or excessive perineal descent. Whether it is a cause or an eff ect of these changes is unclear ( 3, 50 ) . Excessive straining or childbirth may weaken the vaginal septum. Consequently, during defecation a pressure gradient is created between the higher intrarectal pressure and lower vaginal pressure, producing a rectocele. Rectocele is usually asymptomatic, and is diagnosed by examination or defecography. Patients may report symptoms such as a feeling of incomplete evacuation, prolonged straining, or vaginal splinting. Some report a vaginal or perineal bulge and others describe a sensation of blockage or inability to evacuate ( 38 ) . Patients may complain of dyspareunia, anorectal / vaginal pain, fecal soiling, and urologic symptoms ( 52 ).
Diagnosis . DRE may reveal an anterior outpouching of the rectal wall, particularly during straining. Bimanual rectal and vaginal examination can further help to confi rm or facilitate diagnosis. A posterior rectocele is diffi cult to detect clinically. Defecography is considered the gold standard for diagnosis of anterior or posterior rectocele, and to measure its size and quantify stool retention. It also provides information regarding coexisting conditions such as rectal mucosal intussusception or excessive perineal descent ( 53 ) . Clinical correlation is important before labeling a rectocele as clinically signifi cant. Rectoceles > 3 cm and those with retention of barium or stool are considered to be clinically signifi cant. Although widely used for identifi cation and staging of rectoceles, defecography cannot predict the outcome of rectocele repair. Anal sphincter pressures, rectal sensation, and rectal compliance are usually normal, but one study found dyssynergia in ~ 50 % of patients with rectocele < 2.5 cm ( 54 ) .
MRI provides good visualization of the rectocele, and dynamic MRI can correlate with pelvic fl oor movements. It is recommended that real-time continuous imaging with a dynamic true fast imaging with steady-state precession sequence should be included in MR protocols to evaluate pelvic fl oor dysfunction in addition to dynamic multiplanar sequences ( 55 ) . A recent study showed that images during the defecation phase can identify abnormal bladder, vaginal, and rectal descent and previously undetected rectoceles that were ≥ 2 cm ( 22 ).
Management
. Th e fi rst approach is to treat any underlying defecation disorder. Fiber supplements, laxatives, timed-toilet training, and behavioral approaches can be eff ective but have not been systematically evaluated. If symptoms persist and DD is identifi ed, biofeedback may help. It is important to identify and treat coexisting psychological disorders and other organic disorders (urogynecological) ( 56, 57 ) . Surgical treatments carry a high risk of recurrence for both rectocele and rectal mucosal intussusception. However, surgery is appropriate for patients with large rectocele ( > 3 or 4 cm) or those with coexisting vaginal prolapse, but aft er failure of medical therapy. In these patients, rectocele repair improves anorectal function by improving rectal sensitivity ( 58 ) .
Surgical repair of a rectocele must be tailored to each patient ' s needs, keeping in mind that uterovaginal and rectal prolapse may coexist, and generally a transperineal repair is superior to transanal repair for both structural and functional outcomes ( 59 ) . In patients with both rectocele and DD, the transanal approach is ideal, although it may compromise anal sphincter pressures. Th e stapled transanal rectal resection approach uses sequential deployments of a gastrointestinal stapling device to resect the redundant anterior and posterior rectal walls, thereby restoring normal rectal anatomy and reducing rectal volume ( 60 ) . However, a recent longterm study demonstrated rapid deterioration in outcomes aft er 18 months ( 61 ).
Descending perineum syndrome
Descending perineum syndrome (DPS) is characterized by ballooning and excessive descent of the perineum, oft en several centimeters below the bony outlet of the pelvis, during straining ( 62 ) ( Figure 4 ) .
Typically, patients present with a long history of painful defecation, excessive straining, and sense of incomplete evacuation or fecal incontinence ( 62 ) . One study showed a link between DPS, fecal incontinence, and abdominal hysterectomy ( 63 ). with slightly higher prevalence in females. Rectal intussusception is oft en present and evacuation is delayed ( 70, 71 ) . Ulceration is thought to occur during repeated forceful straining against an immobile pelvic fl oor or DD together with trauma from digital manipulations and ischemic necrosis of the prolapsing rectal mucosa ( 72 ) . Patients present with rectal bleeding and / or pain, mucus discharge, straining and tenesmus, and a feeling of incomplete evacuation. A majority of these patients use digital maneuvers but rarely admit. Approximately 55 % present with constipation and 20 -40 % with diarrhea, and 25 % of the patients are asymptomatic, and 25 % are misdiagnosed or treated as infl ammatory bowel disease. In some patients, an underlying psychologic disorder, such as obsessive -compulsive disorder, may be present ( 71 ) .
Diagnosis . Sigmoidoscopy may reveal a small, shallow ulcer with a white slough or hyperemic mucosa on the anterior wall of the rectum ( Figure 5 ). Th e lesions can be multiple (30 % ), ulcerated (57 % ), polypoid (25 % ), or with patches of hyperemic mucosa (18 % ). SRUS is usually found on the anterior or anterolateral wall of the rectum, over a rectal fold, ~ 5 -10 cm from anus ( 73 ) . 72 Histologically, the mucosa appears elongated with distorted glands DPS can be diagnosed on physical examination, or defecography. Th e most common abnormality is > 4 cm perineal descent at rest or ≥ 3 cm perineal descent during a maximal push eff ort ( 64 ) . A perineometer, which measures the strength of voluntary contractions of the pelvic fl oor muscles, may be useful ( 65 ) .
Dynamic MR imaging demonstrates simple or complex organ descent in all pelvic compartments and may become standard preoperative evaluation for pelvic fl oor abnormalities. Th e MR images facilitate planning of surgery and can increase rate of successful outcome, but are expensive and not widely available ( 66 ) .
Management . Treatment consists of mainly correcting the excessive straining and use of an artifi cial device defecom, a polycarbonate plate with two separate holes for passing urine and stool and a built-in hump that supports the perineum when sitting on a commode. Th e defecom together with biofeedback therapy may improve symptoms in ~ 50 % of the patients ( 67 ) . Pelvic fl oor retraining may also be useful but there is no information and the extent of perineal descent appears to be a useful predictor of response to retraining. Th e defecom and a similar device " Colorec " are unavailable in the United States and not FDA approved.
Until recently, there was no surgical option for isolated DPS. However, recently there was a retrospective case series of nine women who underwent isolated retro-anal levator plate myorrhaphy for symptomatic DPS ( 68 ) . Th e mean reduction of perineal descent was 1.08 cm (0 -1.5) reported aft er 9 months. Th ere were improvements in stress urinary incontinence (100 % ), frequency, nocturia, urgency (66 % ), dysuria (75 % ), fecal incontinence (100 % ), dyschezia (87 % ), dyspareunia (80 % ), and cystocele and rectocele (75 % ). A prospective controlled study is needed to validate this result.
Solitary rectal ulcer syndrome
Solitary rectal ulcer syndrome (SRUS) is characterized by erythema and single / few ulcers. Its etiology remains obscure but is oft en associated with evacuation disorders. Th e annual incidence of SRUS is 1 -3.6 / 100,000; 80 % of patients are < 50 years of age ( 69 ) 
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at the base, with an edematous fi broblast-rich lamina propria and thickened inner circular muscular layer ( 74 ) . When the glands migrate down to the submucosa, bleeding may occur. Pathognomonic features in SRUS include: decussation of the two muscularis layers, nodular induration of the inner layer, and grouping of outer longitudinal layers into bundles ( 75 ) . Biopsy is needed to diff erentiate SRUS from ulcers due to other etiologies (nonsteroidal antiinfl ammatory drugs, malignancy, endometriosis) ( 76, 77 ) . Defecography may show other abnormalities such as rectal mucosal intussusception in 45 -80 % of subjects. Barium enema is unreliable ( 78 ) . Anorectal manometry does not help in establishing the diagnosis or predicting therapeutic response; however, it may reveal a number of physiological abnormalities such as dyssynergia in 80 % of patients or a hypersensitive rectum, and prolonged balloon expulsion test ( 79 ) . Ultrasonography may show marked thickening of the IAS, submucosa, and EAS, as well as rectal wall and muscularis propria ( 75 ) .
Management . Behavioral therapy remains the mainstay of treatment and includes reducing excessive straining, spending < 5 min during evacuation, and discontinuing the use of digital maneuvers. Th ese recommendations, together with biofeedback therapy, improved symptoms in 67 % of patients, with sigmoidoscopic improvement in 30 % ( 73 ). A high-fi ber diet showed a variable response rate of 19 -70 % , suggesting that although diet helps by itself, it is insuffi cient. Local treatment with topical steroids and sulphasalazine is generally ineff ective. Although there are limited data, sucralfate enemas and topical human fi brin sealant have been tried ( 80 ) . A recent study suggests that Argon plasma coagulation may be useful in controlling bleeding and improving healing of ulcers, but controlled studies are lacking ( 81 ) . Biofeedback therapy appears to be eff ective, although RCTs are scarce. One study showed that 75 % (12 / 16) of patients had symptomatic improvement with biofeedback therapy and 31 % (5 / 16) had ulcer resolution on sigmoidoscopy ( 82 ) . Mucosal fl ow improved in patients who felt subjectively better aft er biofeedback. Another prospective study of 11 patients with refractory SRUS showed that biofeedback therapy improved straining eff ort and stool frequency, digital maneuvers were discontinued in 45 % , and bleeding ceased in 56 % of patients. Ulcer healing was reported in 10 patients: 4 had complete healing, 2 had > 50 % healing, and 4 had < 50 % healing ( 72 ) .
Rectopexy with or without anterior resection should be performed in highly selected cases. Outcomes of surgery are oft en disappointing, because of either persistent symptoms, postoperative bleeding, or sexual dysfunction ( 83,84 ) ( Figure 6 ). 
